|
**Update: Per the order signed February 9, 2010, the terms of the settlement have
been approved.
Click here to view the final approval order.**
There is a Class Action Settlement with Merck & Co., Inc., Schering-Plough Corporation,
Merck/Schering-Plough Pharmaceuticals, and certain other related entities (the “defendants”)
concerning the prescription drugs Vytorin® and Zetia®. The name of the lawsuit is
In re Vytorin/Zetia Marketing, Sales Practices and Products Liability Litigation,
Master Docket No. 08-0285(DMC), pending in the United States District Court for
the District of New Jersey.
This lawsuit claims that Vytorin® and Zetia® were marketed as being more effective
than other anti-cholesterol drugs, and were sold at higher prices when they were
no more effective than less expensive anti-cholesterol drugs. The defendants deny
any wrongdoing and are settling this lawsuit to avoid the costs and expenses of
further litigation.
If you are a Consumer and you paid (or are obligated to pay) for
Vytorin® and Zetia® from November 1, 2002 through September 17, 2009, please
click here to read detailed information.
|
If you are a Third-Party Payor (TPP) who reimbursed or paid for
Vytorin® and Zetia® from November 1, 2002 through September 17, 2009, please
click here to read detailed information.
|
|